SS
RVNC

Steve Schonfeld’s Revance Therapeutics, Inc. RVNC Stock Holding History

Steve Schonfeld’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$519K – 2483
2024
Q3 		$519K Buy
+100,000
New +$497K ﹤0.01% 1414

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steve Schonfeld's RVNC Position: Q1 2025 in Review

Steve Schonfeld sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 13,400 shares — an estimated $40.7K sold.

Steve Schonfeld first reported a position in RVNC in Q4 2017 and held it in 12 quarters. The position peaked at $5.86M in Q3 2022. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • Steve Schonfeld reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • Steve Schonfeld sold 13,400 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $40.7K.
  • Steve Schonfeld first reported a position in Revance Therapeutics, Inc. in Q4 2017 and held it in 12 quarters.
  • Steve Schonfeld's Revance Therapeutics, Inc. position peaked at $5.86M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.